欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0316/003
药品名称bicaVera 2,3% Glucose, 1,75 mmol/l Calcium, Peritonealdialyselösung
活性成分
    • glucose monohydrate 25.0 g/l
    • magnesium chloride hexahydrate 0.0 g/l
    • sodium chloride 6.0 g/l
剂型Solution for peritoneal dialysis
上市许可持有人Fresenius Medical Care Deutschland GmbH Else-Kroener-Str. 1 D-61352 Bad Homburg v.d.H. Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Cyprus (CY)
      bicaVera 2,3% Glucose, 1,75 mmol/l Calcium,
    • Luxembourg (LU)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
      BicaVera 4,25% Glucose Peritonealdialyselösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
许可日期2001/11/28
最近更新日期2024/06/20
药物ATC编码
    • B05DB Hypertonic solutions
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Bibliographic Article 4.8 (a) (ii)
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase